Cellectar Biosciences, Inc. made an exciting announcement on November 2, 2023. They revealed their plans to unveil the highly anticipated ...
Cellectar Biosciences is bolstering its commercialization leadership team in anticipation of the highly anticipated release of pivotal data for iopofosine ...
Cellectar Biosciences, Inc. has recently achieved a significant milestone in their pursuit of developing innovative treatments for Waldenstrom's macroglobulinemia (WM). ...
On September 5, 2023, Cellectar Biosciences made a groundbreaking announcement regarding its private placement financing, securing an impressive sum of ...
Cellectar Biosciences, a cutting-edge clinical biopharmaceutical company dedicated to revolutionizing cancer treatment, has just announced a groundbreaking private placement financing ...
Cellectar Biosciences unveiled groundbreaking findings at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting on June 28, ...